← The Wire
LBRXNasdaq
LB PHARMACEUTICALS INC
Pharmaceutical Preparations · DE · CIK 1691082
Develops pharmaceutical product candidates, primarily LB-102, through research and clinical trials
red 8-K · 90d
$815M
Market cap
$32.64
Last close
+2.3%
1D
+9.3%
5D
367K
Volume
Price · last 39 sessions+2.5%
May 4L $27.02 · H $32.88Jun 29
20
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 10, 20268-KShareholder VoteJun 9, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 2026S-1S-1Apr 6, 202610-K10-KMar 26, 20268-KResults of OperationsMar 26, 20268-KExecutive ChangeMar 16, 20268-KExecutive Change · Reg FD DisclosureMar 10, 2026SC 13D/ASC 13D/AFeb 10, 20268-KMaterial Agreement · Equity IssuanceFeb 5, 20268-KMaterial AgreementNov 13, 20258-KCompany UpdateNov 12, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KBylaw AmendmentSep 12, 2025424B4424B4Sep 12, 2025S-1/AS-1/ASep 8, 2025S-1S-1Aug 22, 2025
Similar companies
Comparable business profile · signals at a glance